As researchers race to develop a COVID-19 vaccine, two Rutgers Global Health Institute core faculty members discuss how clinical trials work, the ethics of developing and distributing a vaccine, safety and efficacy in clinical trials, and what a successful vaccine may mean. Associate Professor Shobha Swaminathan is principal investigator at the Rutgers New Jersey Medical School Clinical Research Center and the medical director of Infectious Diseases Practice at University Hospital, and Michael K. Gusmano is a bioethicist and professor of health policy at the Rutgers School of Public Health. To read the full story.
Recent Posts
- Peptides for Weight Loss: What to Know, According to Experts.
- New NJACTS Publication
- Nine Dimensions of Authentic Community Engagement
- Rutgers study finds patients with schizophrenia are less likely to be rehospitalized when given antipsychotic injections.
- Taking Proactive Steps, Rutgers Provides Free Narcan to the Community.
Categories
- News (2,098)
- Publication (1)